Santuza Maria Ribeiro Teixeira
Overview
Explore the profile of Santuza Maria Ribeiro Teixeira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pereira S, Alves F, Teixeira S
Microorganisms
. 2025 Jan;
12(12.
PMID: 39770779
Animal trypanosomiasis, such as nagana, surra, and dourine, represent a significant challenge to animal health and economic development, especially in tropical and subtropical regions where livestock production is an essential...
2.
Costa M, Alves C, Guimaraes da Fonseca F, Sato H, Rocha R, Carvalho A, et al.
Einstein (Sao Paulo)
. 2024 Nov;
22:eAO0495.
PMID: 39607111
Objective: Previous studies indicated that face masks reduce the probability of infection by SARS-CoV-2 but did not examine the relationship between SARS-CoV-2 viral load and mask usage. This study analyzed...
3.
Ramalho-Pinto C, Ventura L, Ventura L, Camatta G, da Silveira-Nunes G, Silveira-Nunes G, et al.
J Leukoc Biol
. 2024 Oct;
117(2).
PMID: 39432758
Although the SARS-CoV-2 infection has established risk groups, identifying biomarkers for disease outcomes is still crucial to stratify patient risk and enhance clinical management. Optimal efficacy of COVID-19 antiviral medications...
4.
Najera C, Soares-Silva M, Maeda F, DaRocha W, Meneghelli I, Mendes A, et al.
Microbes Infect
. 2024 Jul;
26(8):105385.
PMID: 38950642
Trypanosoma cruzi, the etiological agent of Chagas' disease, can infect both phagocytic and non-phagocytic cells. T. cruzi gp82 and gp90 are cell surface proteins belonging to Group II trans-sialidases known...
5.
Dias Assis B, Gomes I, Castro J, Rivelli G, de Castro N, Gomez-Mendoza D, et al.
Nanomedicine (Lond)
. 2023 Sep;
18(18):1175-1194.
PMID: 37712604
To develop, characterize and evaluate an oil/water nanoemulsion with squalene (CTVad1) to be approved as an adjuvant for the SpiN COVID-19 vaccine clinical trials. Critical process parameters (CPPs) of CTVad1...
6.
Burle-Caldas G, Grazielle-Silva V, Faustino L, Teixeira S
Adv Exp Med Biol
. 2023 Jul;
1429:111-125.
PMID: 37486519
Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, is an illness that affects 6-8 million people worldwide and is responsible for approximately 50,000 deaths per year. Despite intense research...
7.
Sato H, Costa M, Takahashi R, Lourenco K, Guimaraes N, Alves C, et al.
Einstein (Sao Paulo)
. 2023 Jul;
21:eAE0115.
PMID: 37436266
This study proposes a strategy for large-scale testing among a large number of people for the early diagnosis of COVID-19 to elucidate the epidemiological situation. Pool testing involves the analysis...
8.
Goes W, Brasil C, Reis-Cunha J, Coqueiro-Dos-Santos A, Grazielle-Silva V, de Souza Reis J, et al.
Genomics
. 2023 Jun;
115(5):110661.
PMID: 37263313
We report the sequencing and assembly of the PH8 strain of Leishmania amazonensis one of the etiological agents of leishmaniasis. After combining data from long Pacbio reads, short Illumina reads...
9.
Marcelino T, Fala A, da Silva M, Souza-Melo N, Malvezzi A, Klippel A, et al.
J Biol Chem
. 2023 May;
299(7):104857.
PMID: 37230387
The TcK2 protein kinase of Trypanosoma cruzi, the causative agent of Chagas disease, is structurally similar to the human kinase PERK, which phosphorylates the initiation factor eIF2α and, in turn,...
10.
Alves H, de Araujo J, Fonseca P, Moreira F, Bonfim D, Queiroz D, et al.
Viruses
. 2022 Dec;
14(12).
PMID: 36560750
Since its first identification in Brazil, the variant of concern (VOC) Gamma has been associated with increased infection and transmission rates, hospitalizations, and deaths. Minas Gerais (MG), the second-largest populated...